ENDO: Testosterone-Replacement Noninferior to Placebo for Cardiovascular Events
Findings seen in middle-aged men with preexisting or high risk of cardiovascular disease and hypogonadism
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.